This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 387 
1 out of 12,269 
Years Active: 2016-2021
Title: Innovative Contributions of Inventor Alexey Gromov
Introduction
Alexey Gromov, an inventive mind residing in Erkrath, Germany, is recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of eight patents, Gromov has been instrumental in developing compounds that hold promise for treating cardiovascular and renal diseases. His groundbreaking work illustrates the vital role inventors play in advancing medical science.
Latest Patents
Among his latest inventions is a patent for substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives. This innovation encompasses compounds that offer potential benefits in pharmaceutical compositions aimed at treating or preventing cardiovascular and renal diseases. Another key patent from Gromov is related to amino-substituted imidazo[1,2-A] pyridinecarboxamides, which also targets cardiovascular disorders. These patents not only showcase Gromov's ingenuity but also reflect his commitment to improving health outcomes through innovative medications.
Career Highlights
Gromov's impressive career has been marked by his tenure at Bayer Pharma and Bayer Aktiengesellschaft. His work at these esteemed companies has provided him with a platform to pursue extensive research and development in the pharmaceutical sector. His contributions have led to the enhancement of therapeutic options available for various diseases, establishing him as a respected inventor in the industry.
Collaborations
Throughout his career, Gromov has collaborated with notable colleagues, including Alexandros Vakalopoulos and Frank Wunder. These partnerships have been crucial in advancing his research projects, as collaborative efforts often lead to the exchange of innovative ideas and methodologies that can enhance the quality and efficacy of medical treatments.
Conclusion
Alexey Gromov stands out as a prominent figure in the realm of pharmaceutical innovations. His eight patents reflect his dedication to developing effective treatments for serious health conditions. Through his career at Bayer and his collaborations, Gromov continues to make impactful contributions that advance the field of medical science, demonstrating the essential role inventors play in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile